Cyclophosphamide/dexamethasone: Non-alcoholic steatohepatitis: case report

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1233, 2009-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ketoprofen: Non-alcoholic fatty liver disease and steatohepatitis: case report

Reactions Weekly, Vol. 1, Iss. 1348-1349, 2011-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Emerging drugs for non-alcoholic steatohepatitis

By Tomeno Wataru Yoneda Masato Imajo Kento Ogawa Yuji Kessoku Takaomi Saito Satoru Eguchi Yuichiro Nakajima Atsushi

Expert Opinion on Emerging Drugs, Vol. 18, Iss. 3, 2013-09 ,pp. : 279-290

Informa Healthcare

Access to resources Recommend Favorite

Evolving therapies for non-alcoholic steatohepatitis

By Tilg Herbert Moschen Alexander R

Expert Opinion on Drug Discovery, Vol. 9, Iss. 6, 2014-06 ,pp. : 687-696

Informa Healthcare

Access to resources Recommend Favorite

Dexamethasone/temozolomide: Chemotherapy-associated steatohepatitis: case report

Reactions Weekly, Vol. 1, Iss. 1417, 2012-01 ,pp. : 19-20

Adis International

Access to resources Recommend Favorite

Role of microRNAs in Non-Alcoholic Steatohepatitis

Current Pharmaceutical Design, Vol. 16, Iss. 17, 2010-06 ,pp. : 1952-1957

Bentham Science Publishers

Access to resources Recommend Favorite